Literature DB >> 31570977

Changing trends in mortality in systemic lupus erythematosus? An analysis of SLE inpatient mortality at University Hospital Coventry and Warwickshire NHS Trust from 2007 to 2016.

Himashi Anver1, Shirish Dubey2, James Fox3.   

Abstract

The aim of this study was to determine the causes of mortality in patients with systemic lupus erythematosus (SLE) at the University Hospital Coventry and Warwickshire (UHCW) NHS Trust over a 10 year period. This was a retrospective study of patients who had died in UHCW NHS Trust between 2007 and 2016, where SLE or lupus was mentioned on the death certificate. Ethics approval was obtained from the Research and Development. We identified 22 patients out of 1979 admissions with SLE who had died during the period between 2007 and 2016, 7 of these patients were under 50 years of age. The leading cause of death was infection with pneumococcus being associated with two deaths. Active disease was associated with younger age at death. Median age at death was 58.5 years, with median duration of disease of 14.5 years. Constitutional and mucocutaneous features were the most common items scoring on disease activity, seen in 68.2% and 45.45%, respectively. We identified three patients with biopsy proven lupus nephritis and one patient with CNS lupus. Surprisingly, none of the patients died because of vascular problems. The study suggests a changing trend in SLE mortality with none of the deaths in this cohort being due to cardiovascular or cerebrovascular disease. Infection continues to be the biggest reason for mortality in this cohort and greater emphasis is needed on vaccination for preventable infections like pneumococcus.

Entities:  

Keywords:  Lupus; Mortality; Systemic lupus erythematosus

Mesh:

Year:  2019        PMID: 31570977     DOI: 10.1007/s00296-019-04450-1

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  30 in total

1.  Evolving spectrum of mortality and morbidity in SLE.

Authors:  M B Urowitz; D D Gladman
Journal:  Lupus       Date:  1999       Impact factor: 2.911

2.  Fluctuation of anti-Ro/SS-A antibody levels in patients with systemic lupus erythematosus and Sjögren's syndrome: a prospective study.

Authors:  S Praprotnik; B Bozic; T Kveder; B Rozman
Journal:  Clin Exp Rheumatol       Date:  1999 Jan-Feb       Impact factor: 4.473

3.  Predictors of survival in systemic lupus erythematosus.

Authors:  Nuntana Kasitanon; Laurence S Magder; Michelle Petri
Journal:  Medicine (Baltimore)       Date:  2006-05       Impact factor: 1.889

4.  Causes of death in Korean patients with systemic lupus erythematosus: a single center retrospective study.

Authors:  W U Kim; J K Min; S H Lee; S H Park; C S Cho; H Y Kim
Journal:  Clin Exp Rheumatol       Date:  1999 Sep-Oct       Impact factor: 4.473

5.  The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults: Executive Summary.

Authors:  Caroline Gordon; Maame-Boatemaa Amissah-Arthur; Mary Gayed; Sue Brown; Ian N Bruce; David D'Cruz; Benjamin Empson; Bridget Griffiths; David Jayne; Munther Khamashta; Liz Lightstone; Peter Norton; Yvonne Norton; Karen Schreiber; David Isenberg
Journal:  Rheumatology (Oxford)       Date:  2018-01-01       Impact factor: 7.580

6.  Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus.

Authors:  K Manger; B Manger; R Repp; M Geisselbrecht; A Geiger; A Pfahlberg; T Harrer; J R Kalden
Journal:  Ann Rheum Dis       Date:  2002-12       Impact factor: 19.103

7.  Combined oral contraceptives in women with systemic lupus erythematosus.

Authors:  Michelle Petri; Mimi Y Kim; Kenneth C Kalunian; Jennifer Grossman; Bevra H Hahn; Lisa R Sammaritano; Michael Lockshin; Joan T Merrill; H Michael Belmont; Anca D Askanase; W Joseph McCune; Michelene Hearth-Holmes; Mary Anne Dooley; Joan Von Feldt; Alan Friedman; Mark Tan; John Davis; Mary Cronin; Betty Diamond; Meggan Mackay; Lisa Sigler; Michael Fillius; Ann Rupel; Frederick Licciardi; Jill P Buyon
Journal:  N Engl J Med       Date:  2005-12-15       Impact factor: 91.245

8.  Mortality in systemic lupus erythematosus.

Authors:  S Bernatsky; J-F Boivin; L Joseph; S Manzi; E Ginzler; D D Gladman; M Urowitz; P R Fortin; M Petri; S Barr; C Gordon; S-C Bae; D Isenberg; A Zoma; C Aranow; M-A Dooley; O Nived; G Sturfelt; K Steinsson; G Alarcón; J-L Senécal; M Zummer; J Hanly; S Ensworth; J Pope; S Edworthy; A Rahman; J Sibley; H El-Gabalawy; T McCarthy; Y St Pierre; A Clarke; R Ramsey-Goldman
Journal:  Arthritis Rheum       Date:  2006-08

9.  Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus.

Authors:  R Cervera; M A Khamashta; J Font; G D Sebastiani; A Gil; P Lavilla; I Doménech; A O Aydintug; A Jedryka-Góral; E de Ramón
Journal:  Medicine (Baltimore)       Date:  1993-03       Impact factor: 1.889

10.  European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies.

Authors:  M Mosca; C Tani; M Aringer; S Bombardieri; D Boumpas; R Brey; R Cervera; A Doria; D Jayne; M A Khamashta; A Kuhn; C Gordon; M Petri; O P Rekvig; M Schneider; Y Sherer; Y Shoenfeld; J S Smolen; R Talarico; A Tincani; R F van Vollenhoven; M M Ward; V P Werth; L Carmona
Journal:  Ann Rheum Dis       Date:  2009-11-05       Impact factor: 19.103

View more
  2 in total

1.  Large-scale mortality gap between SLE and control population is associated with increased infection-related mortality in lupus.

Authors:  Melinda Kedves; Fruzsina Kósa; Péter Kunovszki; Péter Takács; Melinda Zsuzsanna Szabó; Chetan Karyekar; Jennifer H Lofland; György Nagy
Journal:  Rheumatology (Oxford)       Date:  2020-11-01       Impact factor: 7.580

2.  Trends in Hospital Admissions and Death Causes in Patients with Systemic Lupus Erythematosus: Spanish National Registry.

Authors:  Víctor Moreno-Torres; Carlos Tarín; Guillermo Ruiz-Irastorza; Raquel Castejón; Ángela Gutiérrez-Rojas; Ana Royuela; Pedro Durán-Del Campo; Susana Mellor-Pita; Pablo Tutor; Silvia Rosado; Enrique Sánchez; María Martínez-Urbistondo; Carmen de Mendoza; Miguel Yebra; Juan-Antonio Vargas
Journal:  J Clin Med       Date:  2021-12-08       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.